Filing Details

Accession Number:
0001209191-17-044944
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-12 18:08:03
Reporting Period:
2017-07-10
Filing Date:
2017-07-12
Accepted Time:
2017-07-12 18:08:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437786 Immune Design Corp. IMDZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216504 W Lewis Coleman C/o Immune Design Corp.
1616 Eastlake Ave. E., Suite 310
Seattle WA 98102
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-07-10 10,000 $9.00 18,000 No 4 P Indirect By Trust
Common Stock Acquisiton 2017-07-11 2,000 $9.33 20,000 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,000 Indirect By Wife's IRA
Common Stock 40,000 Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $8.85 to $9.20 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  2. The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.30 to $9.35 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.